Our exclusive focus on healthcare allows Newsline analysts and journalists to identify key investment controversies, latest healthcare industry news developments and opportunities throughout the industry. Our editors & analysts are constantly working to deliver leading-edge news and research for the audience seeking latest news stories from the healthcare industry. Health Newsline is an online open-class life sciences, health and medical news source for readers across the globe including healthcare professionals, biotechnology analysts, engaged consumers and medical researchers.
The industry expertise of our editors and analysts is enhanced by the healthcare knowledge of our HealthNewsline Network. The experienced, practical insights of our authors provide support for much of our proprietary and potentially agenda-setting equity research. Content published on HealthNewsline.net is produced by a team of news editors with years of experience in medical, healthcare and life sciences news publication. Visit our editors page to find out more.
With readers around the world, Health Newsline is regarded as one of leading global online health news distributors. With over 1.2 million readership monthly, HealthNewsline publishes the most comprehensive and insightful coverage in life sciences, medical research and health news. We cover news stories from fields such as biotechnology, healthcare, medical devices/equipments, neuroscience, cancer, cardiology, psychiatry, genetics, psychology, dentistry, dermatology, medications, diseases and conditions and other health care related developments across the globe.
In addition to daily health & medical news content sourcing and production, Health Newsline conducts and publishes interviews with healthcare professional and experts in both healthcare industry and academia. We also publish encyclopedic articles on health, medicines, other related subjects to enlighten our readers with recent researches and development.
If you would like to report news or contact us regarding a potential news story, please visit contact page to send us your emails.